The Food and Drug Administration inspected Chicago’s Reproductive Medicine Institute on May 12 for its human cellular, tissue, and gene therapy practices, according to data posted on the FDA’s website.
The inspection’s final report showed no corrective actions were recommended for the institute’s operational management.
The FDA conducts regular checks of facilities nationwide to verify compliance with regulations and laws intended to promote public health, with results made publicly available.
According to its website, the FDA is a federal agency that oversees the safety and quality of human and animal drugs, biological products, medical equipment and tobacco items.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
